Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...

The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.

Novartis’ position about this year’s price increase has been announced during the Q2 2018 earnings call transmitted as a live audio webcast. Vasant Narasimhan, Novartis’ CEO, addressed ...

such as inhaled steroid-containing combination therapies," said Vasant Narasimhan, Global Head Drug Development and Chief Medical Officer for Novartis. "By showing that improved symptom control ...

After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...